Company Filing History:
Years Active: 2023
Title: Danni Ran - Innovator in Tumor Targeting Therapeutics
Introduction
Danni Ran, an accomplished inventor based in Shanghai, China, has made notable contributions to the field of medical science, specifically in the development of targeted therapies for tumors. His work embodies the innovative spirit necessary for tackling complex health issues through advanced biotechnological solutions.
Latest Patents
Danni Ran holds a significant patent concerning a VAP polypeptide, which is instrumental in the preparation of drugs aimed at the targeted diagnosis and treatment of tumors. This groundbreaking invention encompasses highly stable D-configuration polypeptides, known as DVAP and SVAP, which demonstrate high binding activity to the GRP78 protein. Additionally, his patent includes the L-configuration polypeptide LVAP, along with modified model drugs and macromolecule carrier materials. The innovative use of these components contributes greatly to the construction of tumor imaging systems and drug-delivery mechanisms for precise treatment options.
Career Highlights
Danni Ran is affiliated with Fudan University, where he is engaged in pioneering research that bridges the gap between scientific discovery and clinical application. His expertise in polypeptide chemistry and tumor biology positions him as a leading figure in the realm of medical innovation. His patent reflects a commitment not only to advancing scientific knowledge but also to enhancing patient outcomes through targeted therapeutic strategies.
Collaborations
Throughout his career, Danni has collaborated with notable colleagues, including Weiyue Lu and Jiani Mao. These partnerships enhance the research capabilities at Fudan University and facilitate the exchange of ideas necessary for groundbreaking advancements in cancer treatment.
Conclusion
Danni Ran’s innovative contributions exemplify the vital role that inventors play in the pursuit of medical advancements. His patent on VAP polypeptides marks a significant step forward in the targeted treatment of tumors. With his ongoing research and collaborations, Danni continues to be a valuable asset to the scientific community and a beacon of hope for those affected by cancer.